Clinical Trials Browser

Prostate Cancer, Hereditary, 7 × olaparib × 90 days × Clear all

NCT03263650 2026-02-17

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Phase 2 Active not recruiting

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms